Abstract:Background: Current treatment options for Malassezia folliculitis (MF) are limited. Recent research has demonstrated the inhibitory effect of cold atmospheric plasma (CAP) on the growth of Malassezia pachydermatis in vitro, suggesting CAP as a potential therapeutic approach for managing MF. Objectives: The objective of our study is to assess the in vitro antifungal susceptibility of Malassezia yeasts to CAP. Additionally, we aim to evaluate the efficacy and tolerability of CAP in treating patients with MF. Methods: We initially studied the antifungal effect of CAP on planktonic and biofilm forms of Malassezia yeasts, using well-established techniques such as zone of inhibition, transmission electron microscopy, colony count assay and 2,3-bis(2-methoxy-4-nitro-5-sulfophenyl)-2H-tetrazolium-5-carboxanilide salt assay. Subsequently, a randomized (1:1 ratio), active comparator-controlled, observer-blind study was conducted comparing daily CAP therapy versus itraconazole 200 mg/day for 2 weeks in 50 patients with MF. Efficacy outcomes were measured by success rate, negative microscopy rate and changes in Dermatology Life Quality Index (DLQI) and Global Aesthetic Improvement Scale (GAIS) scores. Safety was assessed by monitoring adverse events (AEs) and local tolerability. Results: In laboratory investigations, CAP time-dependently inhibited the growth of Malassezia yeasts in both planktonic and biofilm forms. Forty-nine patients completed the clinical study. At week 2, success was achieved by 40.0% of subjects in the CAP group versus 58.3% in the itraconazole group (p = 0.199). The negative direct microscopy rates of follicular samples were 56.0% in the CAP group versus 66.7% in the itraconazole group (p = 0.444). No significant differences were found in the proportion of subjects achieving DLQI scores of 0/1 (p = 0.456) or in the GAIS responder rates (p = 0.588) between the two groups. Three patients in the CAP group and one patient in the itraconazole group reported mild AEs. Conclusion: CAP demonstrated significant antifungal activity against Malassezia yeasts in vitro and exhibited comparable efficacy to itraconazole in treating MF patients. Without the associated adverse effects of oral antifungal drugs, CAP can be considered a promising and safe treatment modality for MF.

Effects of different cold atmospheric‐pressure plasma sources on the yeast Candida glabrata

Inactivation of <Emphasis Type="Italic">Candida</Emphasis> Strains in Planktonic and Biofilm Forms Using a Direct Current, Atmospheric-Pressure Cold Plasma Micro-Jet

Atmospheric Pressure Cold Plasma As an Antifungal Therapy

Cold plasma treatment triggers antioxidative defense system and induces changes in hyphal surface and subcellular structures of Aspergillus flavus

Evaluation of the Effects of Dielectric Barrier Discharge Plasma on Candida albicans Strains: An in vitro Study

Treatment of Antifungal Resistant Candida Biofilms And Clinical Dermatosis Using A Direct-Current , Atmospheric-Pressure Cold Plasma Micro-Jet

Cold Atmospheric Pressure Plasma Jet Reduces Trichophyton rubrum Adherence and Infection Capacity

Transcriptome analysis of Candida albicans planktonic cells in response to plasma medicine

Sterilization and Drug Susceptibility Study of Candida Albicans Biofilm on Denture Base Resin Treated by Direct and Alternating Current Atmospheric Pressure Cold Plasma Microjet

Inactivation Of Candida Biofilms By Non-Thermal Plasma And Its Enhancement For Fungistatic Effect Of Antifungal Drugs

Effect of Cold Atmospheric Pressure Plasma on the Wheat Seedlings Vigor and on the Inactivation of Microorganisms on the Seeds Surface

Inactivation of Candida albicans Biofilms on Polymethyl Methacrylate and Enhancement of the Drug Susceptibility by Cold Ar/O 2 Plasma Jet

Cold Plasma-Induced Surface Modification of Heat-Polymerized Acrylic Resin and Prevention of Early Adherence of Candida Albicans.

Plasma activated Ezhangfeng Cuji as innovative antifungal agent and its inactivation mechanism

Cold atmospheric plasma therapy for Malassezia folliculitis: Laboratory investigations and a randomized clinical trial

Comparative assessment of UV-C radiation and non-thermal plasma for inactivation of foodborne fungal spores suspension in vitro

Inactivation of multidrug-resistant pathogens and Yersinia enterocolitica with cold atmospheric-pressure plasma on stainless-steel surfaces

Revealing the eukaryocyte response pathway to a cold plasma jet using S.cerevisiae single deletion mutants

Characterization of Live Yeast Cell Derivative (LYCD) Induced by Atmospheric Pressure Cold Plasma and Its Protective Effects on Cells

Surface modifications caused by cold atmospheric plasma sterilization treatment